CBD FAQ

Cannabidiol, or CBD, is a non-intoxicating component of the cannabis plant with enormous therapeutic potential. Researchers are currently studying the effects of CBD on a wide range of conditions including chronic pain, insomnia, PTSD, anxiety, epilepsy, dementia and more.

Extensive preclinical research and some clinical studies have shown that CBD has strong anti-oxidant, anti-inflammatory, anticonvulsant, anti-depressant, anti-psychotic, anti-tumoral, and neuroprotective qualities.

The “endocannabinoid” system is an integral part of our neuro-immuno-endocrine network. This is the system of organ and tissue signaling in the human body that sends and receives chemical messages and is affects for many aspects of human health including mood, pain, inflammation, stress response and immune function.

Our bodies produce their own cannabinoids—endocannabinoids—primarily anandamide, and 2-AG (2-arachidonoylglycerol). A “phytocannabinoid” or plant-derived cannabinoid like CBD or THC can activate the same receptors in the body and have similar or stronger effects than our endocannabinoids. This is similar to how morphine derived from the poppy plant can reduce pain by activating the body’s endorphin receptors.

We know the very specific receptors that THC activates in the body, primarily CB1 and CB2 receptors in the brain, but are still learning all the different rectors CBD interact with- one research article estimated CBD may interact with 65 different receptors in the human body, leading scientists refer to CBD as a “promiscuous” compound.

These endocannabinoid receptors activate in order to maintain, heal, and provide internal stability for many vital systems within our bodies. Although researchers have been able to identify most cannabinoids, much more research needs to be done to find out how each cannabinoid benefits us.

Cannabidiol (CBD) has many health benefits, without producing the psychoactive, “euphoric” effects of THC. “Relaxing but not intoxicating” is how some of our customers have described the effect. So in short NO CBD will not make you feel high.

Cannabinoids (e.g., THC and CBD) are the chemical compounds secreted by cannabis flowers that can affect the human body. They work by imitating compounds our bodies naturally produce, called endocannabinoids, that affect nerve, brain and immune cell activity. 

Currently, there are two known primary cannabinoid receptors: CB1 and CB2 receptors. CB1 receptors are located in the central nervous system, and in some peripheral tissues. They affect appetite, muscle control, pain, cognition, thermoregulation, and our stress response. CB2 receptors are primarily found in immune cells, and at a lower density in the central nervous system. CB2 activation is associated with immune function and immune cell proliferation, inflammation, and pain. Although these two cannabinoid receptors have been studied relatively extensively, there are more cannabinoid receptors being examined.

Two primary endocannabinoid receptors have been identified: CB1, first cloned in 1990; and CB2, cloned in 1993. CB1 receptors are found predominantly in the brain and nervous system, as well as in peripheral organs and tissues, and are the main molecular target of the endocannabinoid ligand (binding molecule), anandamide, as well as its mimetic phytocannabinoid, THC. One other main endocannabinoid is 2-arachidonoylglycerol (2-AG) which is active at both cannabinoid receptors, along with its own mimetic phytocannabinoid, CBD. 2-AG and CBD are involved in the regulation of appetite, immune system functions and pain management

CBD exhibits no effects on humans indicative of any abuse or dependence potential.

To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD.

Chronic use and high doses up to 1,500 mg/day of CBD are reportedly well tolerated in humans.

Nanoemulsions are one of the most interesting delivery systems in the CBD industry. Nanoemulsion-based delivery systems improve the bioavailability of the encapsulated bioactive components and increase CBD stability.

Nanoemulsions are emulsions that have very small particle size. They have some unique characteristics such as small size, increased surface area and less sensitivity to physical and chemical changes, making them ideal formulas in the CBD industry.

Food grade nanoemulsions are being increasingly used in for improving digestibility, efficient encapsulation, increasing bioavailability and targeted delivery. The aforementioned advantages of nanoemulsions over the conventional emulsions increased the utility of nanoemulsions in the CBD industry.

Yes, as long as they are derived from hemp, not marijuana, and contain less than 0.3% THC. No medical marijuana card is required to buy or use hemp-derived CBD products.

Although both hemp and “marijuana” are technically variants of the Cannabis sativa plant, there are significant differences between them. Hemp is considered “industrial” under current regulations, and is defined as having less than 0.3% THC 

In the US, the legal definition of “industrial hemp,” (as defined in Section 7606 of the Agricultural Appropriations Act of 2014), is “the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.” 

Marijuana generally refers to Cannabis sativa plants that have a high concentration of THC, and the word stems from the recreational use of THC rich cannabis for the purpose of getting “high.” Hemp plants possess a high concentration of CBD, with only traces of THC, and hemp extracts are associated with medicinal use.

Products infused with a crystalline CBD isolate, derived and extensively refined from industrial hemp, are available. But single-molecule CBD is thought to be less effective therapeutically than whole plant CBD-rich oil extract. The rich recipe of compounds in medicinal plants exerts healing effects through complementary action. This supports the idea of the “entourage effect”, where mixtures of cannabinoids, their co-occurring terpenes, and perhaps other molecules such as flavonoids and stilbenoids, have a greater positive effect than just CBD or THC alone.

Water-soluble forms of CBD are not naturally occurring products. The process of making a fat-soluble compound, such as CBD, soluble in water, involves a process called nano-emulsion. Nano-emulsion uses high frequency ultrasound to induce a process called cavitation, in which small, water soluble spheres (called liposomes) are formed. The CBD molecules are suspended in the liposomes which float in the water.

Most drug tests screen for the psychoactive compound THC, not cannabidiol (CBD). However, full-spectrum hemp extracts may contain trace amounts of THC, so could cause a positive result when screening urine and blood specimens, especially when taken at high doses. I recommend a prudent and cautious approach to taking CBD rich hemp extracts in the context of urine drug screens.

At low doses of CBD, less than 150mg total per day, it is unlikely that significant drug-herb interactions will occur. However it is always possible that drug-herb interactions can occur, and this is more likely the higher the dose. If you are taking a medication always talk with your health care provider or before trying CBD.

An effective dosage can range from as little as a 5mg of CBD per day up to 150mg per day. Make sure to start low and go slow. Take a few small doses over the course of the day rather than one big dose. Use the same dose for several days. Observe the effects and if necessary adjust the amount. Don’t overdo it.